Precision PCI is a development trend in cardiovascular precision interventional therapy, mainly including fractional flow reserve (FFR), an intravascular functional assessment technique, and intravascular ultrasound (IVUS) and optical coherence tomography (OCT), which are intravascular imaging assessment techniques. The aforementioned diagnostic techniques complement each other, guiding and providing optimal treatment plans for patients with coronary artery disease, especially those with complex coronary artery disease. Together, they provide more valuable clinical indicators for precision PCI, reduce the incidence of major adverse cardiovascular events, and lower the risk of reoperation. In the future, driven by multiple factors such as national policy regulations, the growth of disposable income among Chinese residents, and widespread global recommendations for related technologies, the market prospects for cardiovascular precision interventional therapy are broad. For this reason, based on research into the market, Frost & Sullivan (Frost & Sullivan, abbreviated as 'Frost & Sullivan') has released the 'Independent Market Research Report on Cardiovascular Precision Interventional Therapy'.
The attachment is an excerpted version of the report. If you have further research needs on the market for precise interventional treatment of cardiovascular diseases, please contact us at any time:
Mr. Ma, Frost & Sullivan
Tel: (+86)159-2139-6033
E-mail: fred.mao@frostchina.com
